BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 20616418)

  • 21. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
    Bardhan KD; Morton D; Perry MJ; Sanders DS; Morris P; Rowland A; Thompson M; Mitchell TR; Roberts PM
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1199-204. PubMed ID: 11472323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of omeprazole-based short-term triple therapy in Helicobacter pylori-positive older patients with dyspepsia.
    Moshkowitz M; Brill S; Konikoff FM; Reif S; Arber N; Halpern Z
    J Am Geriatr Soc; 1999 Jun; 47(6):720-2. PubMed ID: 10366173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
    Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
    Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
    Romano M; Marmo R; Cuomo A; De Simone T; Mucherino C; Iovene MR; Montella F; Tufano MA; Del Vecchio Blanco C; Nardone G
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):273-8. PubMed ID: 15017668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of dyspepsia, gastroduodenal ulcer and Helicobacter pylori infection in primary care].
    Gené E; Calvet X; Azagra R; López T; Cubells MJ
    Aten Primaria; 2002 May; 29(8):486-94. PubMed ID: 12031222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
    Koskenpato J; Färkkilä M; Sipponen P
    Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
    Ellenrieder V; Boeck W; Richter C; Marre R; Adler G; Glasbrenner B
    Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
    Kiyota K; Habu Y; Sugano Y; Inokuchi H; Mizuno S; Kimoto K; Kawai K
    J Gastroenterol; 1999; 34 Suppl 11():76-9. PubMed ID: 10616771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin.
    Georgopoulos SD; Ladas SD; Karatapanis S; Mentis A; Spiliadi C; Artikis V; Raptis SA
    Dig Dis Sci; 2000 Jan; 45(1):63-7. PubMed ID: 10695615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary antibiotic resistance and effectiveness of Helicobacter pylori triple therapy in ulcero-inflammatory pathologies of the upper digestive tract.
    Aguemon B; Struelens M; Devière J; Denis O; Golstein P; Salmon I; Nagy N
    Acta Gastroenterol Belg; 2005; 68(3):287-93. PubMed ID: 16268413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori eradication: influence of interleukin-1beta -31 C/T polymorphism.
    Rech TF; Mazzoleni LE; Mazzoleni F; Francesconi CFM; Sander GB; Michita RT; Nabinger DD; Milbradt TC; Torresini RJS; Simon D
    Braz J Infect Dis; 2018; 22(4):311-316. PubMed ID: 30048609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori eradication in peptic dyspepsia.
    Lule GN
    East Afr Med J; 2005 Dec; 82(12):601-2. PubMed ID: 16619702
    [No Abstract]   [Full Text] [Related]  

  • 33. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
    Sung JJ; Chan FK; Wu JC; Leung WK; Suen R; Ling TK; Lee YT; Cheng AF; Chung SC
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1079-84. PubMed ID: 10468684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin.
    Bigard MA; Delchier JC; Riachi G; Thibault P; Barthelemy P
    Aliment Pharmacol Ther; 1998 Apr; 12(4):383-8. PubMed ID: 9690730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy.
    Lindsetmo RO; Johnsen R; Revhaug A
    Scand J Gastroenterol; 1998 Mar; 33(3):231-5. PubMed ID: 9548613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azithromycin based triple therapy versus standard clarithromycin based triple therapy in eradication of Helicobacter pylori infection in Iran: a randomized controlled clinical trial.
    Sarkeshikian SS; Iranikhah A; Ghadir MR
    Turk J Gastroenterol; 2013; 24(1):10-4. PubMed ID: 23794338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triple therapy with omeprazole, amoxicillin and clarithromycin is effective against Helicobacter pylori infection in gastric ulcer patients as well as in duodenal ulcer patients. Results of a randomized controlled trial in Japan.
    Habu Y; Mizuno S; Hirano S; Kiyota K; Inokuchi H; Kimoto K; Nakajima M; Kawai K
    Digestion; 1998; 59(4):321-5. PubMed ID: 9693202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
    Labenz J; Blum AL; Bolten WW; Dragosics B; Rösch W; Stolte M; Koelz HR
    Gut; 2002 Sep; 51(3):329-35. PubMed ID: 12171952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.
    Luzza F; Giglio A; Ciliberto E; Belmonte A; Cavaliere C; Saccà N; Frandina C; Fiocca R; Trimboli V; Pallone F
    Clin Ther; 2001 May; 23(5):761-70. PubMed ID: 11394734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.